Delivery Order SPE2DB20D3103-SPE2DB25FQ4Y0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $7,131.73. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for ultimate completion by August 27, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $21,218.77. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $55,353.92. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 20, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The work will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $36,722.05. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract ceiling value of $26,755.38. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 10,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $31,845.93. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 15, 2025. The order is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4Y0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $14,834.36. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is due for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies critical medical commodities to federal healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company has established itself as a key vendor through its extensive portfolio of pharmaceutical products and medical supplies delivered under multiple competitively awarded contracts with the DLA. This particular order for Eliquis, an anticoagulant medication, represents a routine fulfillment of pharmaceutical needs supporting military and veteran healthcare operations. The company's demonstrated capability in meeting federal procurement standards through open competition, combined with its significant prime contract vehicle with DLA, positions AmerisourceBergen as a reliable supplier for ongoing military pharmaceutical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 9/27/25 |